Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

INDIA: New TB Drugs Being Tested in India


DNA: Daily News & Analysis (India) (03.01.13) Aids Weekly Plus

India Health Minister Ghulam Nabi Azad said on March 1 that Indian research institutes are conducting trials to test new TB drugs, including drugs to treat currently drug-resistant TB. Drugs the institutes are testing include Delaminid, Bedaquiline, and PA-824, to treat both drug-sensitive and drug-resistant TB. The All India Institute of Medical Sciences, New Delhi, and the National Institute of Research in TB, Chennai, are taking part in global trials for the new TB drug Bedaquiline (TMC207). Azad noted the Drug Controller General of India (DCGI) had not received an application granting permission for a US drug. Per India’s drug and cosmetic rules, DCGI must grant approval for any new drug to be introduced in the Indian market. Azad declared that, currently, the replacement of drugs used under the Revised National Tuberculosis Control Programme was not required, adding that patients with drug-resistant TB are treated with a regimen containing drugs to which the TB bacillus was not resistant.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in March 4, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.